Advertisement

Microcarrier-Facilitated Cultures for Fibroblastic and Epithelial Cells

  • Menemse Kiremitci
  • Ismet Gurhan
  • Erhan Piskin
Part of the NATO ASI Series book series (NSSA, volume 218)

Abstract

Microcarrier-facilitated cell culture is an established technique for the growth of anchorage-dependent mammalian cells on an industrial scale1,2. In this approach, cells are propagated on the surface of small solid spheres, kept in suspension in the culture medium by slow stirring. Microcarriers must have the desired surface properties (wetability, surface charge, etc.) in order to support cell attachment and growth. They are non-toxic, non-rigid, transparent particles 100–220μ in diameter. Therefore, microcarrier cultures have the highest surface-to-volume ratio (S/V=150) of any other cell culture system. Furthermore, less labor, materials and media are required to produce a given quantity of cells in microcarrier cultures when compared to other systems. Microcarriers also have the best scale-up potential of any cell culture system3. Today microcarriers are used routinely on a large scale for the production of many important biologicals (viral vaccines, tissue type plasminogen activator and β-interferon). Institute Merieux produced inactivated polio and rabies vaccines in Vero cells using 1000 liter microcarrier cultures2.

Keywords

Tissue Type Plasminogen Activator Rabies Vaccine Microcarrier Culture Support Cell Attachment Transparent Particle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A.L. van Wezel, Nature 216: 64, 1967.PubMedCrossRefGoogle Scholar
  2. 2.
    B.J. Montagnon, Vincent, J.C. Falquet, and B. Fangel, Develop. Biol. Stand. 55: 37, 1984.Google Scholar
  3. 3.
    S. Reuveny, Adv. Biotecnol. Process. 2, 1, 1983.Google Scholar
  4. 4.
    M. Hirtenstein, J. Clark, G. Lindgren, and P. Vretblad, Develop. Biol. Stand. 46, 109, 1980.Google Scholar
  5. 5.
    S. Reuveny, L. Silberstein, A. Shahar, E. Freeman, A. Mizrahi, In Vitro 18, 92, 1982.PubMedCrossRefGoogle Scholar
  6. 6.
    V. Nielsen and A. Johansson, Develop. Biol. Stand. 46, 131, 1980.Google Scholar
  7. 7.
    M.D. Pierschbacker and E. Rouslahti, Nature 309: 30, 1984.CrossRefGoogle Scholar
  8. 8.
    M. Kiremitci, P.h.D. Thesis, Hacettepe University, Ankara, 1988.Google Scholar
  9. 9.
    M. Kiremitci, I. Gurhan, E. Piskin, Growth Characteristics and FMD Virus Susceptibilities of BHK-21 Cells Proliferated on PHEMA microcarriers, Proc. of 9th ESACT Meeting, 1980.Google Scholar
  10. 10.
    M. Kiremitci, M. Ozilgen, E. Piskin, Cell Culturing Characteristics of Newly Developed PHEMA Microcarriers, Biomat. Artif. Cells and ARtif. Organs (in press).Google Scholar
  11. 11.
    M. Kiremitci, M. Ozilgen, E. Piskin, Attachment and Growth Kinetics of Anchorage-Dependent BHK Cells on Microcarriers, Enzyme Microb. Technol. (in press)Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Menemse Kiremitci
    • 1
  • Ismet Gurhan
    • 2
  • Erhan Piskin
    • 1
  1. 1.Chemical Engineering DepartmentHacettepe UniversityBeytepe, AnkaraTurkey
  2. 2.Foot and Mouth Disease InstituteAnkaraTurkey

Personalised recommendations